Novo Nordisk says Ozempic helped patients with Type 2 diabetes in one new way
Novo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related...
Novo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related...
Viking Therapeutics Inc.’s stock rose another 8% Wednesday to extend its week-to-date gains to 145%, as analysts weighed in on...
For all the attention paid to the highflying tech giants dubbed the Magnificent Seven, there’s another grouping that has kept...
A record number of people in the U.S. will turn 65 this year. Here’s how the phenomenon known as Peak...
The controlling shareholder of weight-loss drug maker Novo Nordisk on Monday said it’s buying a provider of drug manufacturing for...
Fourth-quarter earnings season in Europe is still in its early days, but the largest companies on the Continent are mostly...
Novo Nordisk on Wednesday said its fourth-quarter profit surged by nearly two-thirds, driven by the popularity of its weight-loss drugs...
Novo Nordisk has entered research collaboration agreements with Omega Therapeutics Inc. and Cellarity Inc. on new treatments for obesity management,...
The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and...
LifeMD Inc., a virtual primary care provider, said Wednesday it’s teaming up with Medifast Inc. MED, -12.08% to create a...